Therefore, HSP27 inhibition is also efficient in inducing death signaling in these glioma cells, and similar to C1.1 cells (low SPARC, low pAKT) inhibition increased sensitivity to lower doses of TMZ. The gene discussed is SPARC; the disease is central nervous system cancer.